Bilateral intradentate injections of 3.0 lg of colchicine induced a substantial loss of granule cells and damage to the overlying pyramidal cell layer in region CA1 in adult male Long-Evans rats. All rats with such lesions showed a significant associative learning deficit in an olfactory discrimination task, while being unimpaired in the procedural component of this task. Injection of a partial selective 5-HT 4 agonist (SL65.0155; 0.01 mg/kg, i.p., vs. saline) before the third of six training sessions enabled complete recovery of associative learning performance in the lesioned rats. Activation of 5-HT 4 receptors by a selective agonist such as SL65.0155 might therefore provide an opportunity to reduce learning and memory deficits associated with temporal lobe damage, and could be useful for the symptomatic treatment of memory dysfunctions related to pathological aging such as Alzheimer's disease.
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Introduction
Although the etiology of Alzheimer's disease (AD) is still under discussion, neurofibrillary tangles and amyloïd plaques have been recognized as the pathological hallmarks of this disease since the early report by Alzheimer (1907) . These hallmarks are associated with evidence of neurodegeneration in a variety of brain regions involved in cognitive functions, including the basal forebrain, the hippocampus and some retrohippocampal regions such as the entorhinal cortex. Since the pioneering work by Perry et al. (1978) , AD-related cognitive dysfunctions have been attributed to cholinergic degeneration in the basal forebrain, but other neurotransmitter systems are also altered, including the norepinephrinergic, dopaminergic, and serotonergic systems (see Palmer, 2002 for a review), and all contribute to cognitive functions. These non-cholinergic systems provide other potential targets for symptomatic intervention, either alone or in combination with pro-cholinergic compounds.
Concerning the serotonergic system, the substantial expression of 5-HT 4 receptors in limbic areas suggests that this receptor type could contribute to learning and memory functions, perhaps indirectly by modulating acetylcholine release in these structures (Consolo, Arnaboldi, Giorgi, Russi, & Ladinsky, 1994) . Furthermore, there is evidence for a loss of 5-HT 4 receptors in the cortex (À23%), and particularly the hippocampus (À66%), of AD patients (Reynolds et al., 1995) .
In studies on rats, an increasing body of evidence supports a significant role of the 5-HT 4 receptor type in learning and memory. Most of these studies have observed a beneficial effect of the relatively non-selective agonists BIMU-1 and BIMU-8 on associative learning in an olfactory discrimination task (Marchetti-Gauthier, Roman, Dumuis, Bockaert, & Soumireu-Mourat, 1997), on social memory (Letty et al., 1997) , on acquisition of an operant autoshaping task (Meneses & Hong, 1997) , and on passive avoidance in mice subjected to scopolamine-induced amnesia (Galeotti, Gheraldini, & Bartolini, 1998) . More selective compounds such as RS 17017 and RS 67333 have also been shown to enhance cognition after hypoxia-induced amnesia in mice (Gherlardini et al., 1994 ) and on a delay matching-to-sample task in aged primates (Terry et al., 1998) . Similar observations were made in rats tested for olfactory associative discrimination task (Marchetti et al., 2004; Marchetti, Dumuis, Bockaert, Soumireu-Mourat, & Roman, 2000) and more recently in the delayed spontaneous alternation task (Mohler et al., 2007) . These 5-HT 4 agonists were also shown to attenuate atropine-induced memory deficits in a water-maze task (Fontana, Daniels, Wong, Clark, & Eglen, 1997) .
As therapeutic agents, however, these compounds generate several undesirable side effects such as increased gastric motility, cardiac ionotropy and tachycardia, as well as stimulation of the
